TNBI / Tanke Biosciences Corporation - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Via EDGAR

Via EDGAR Securities and Exchange Commission Division of Corporate Finance Office of Trade and Services Washington, DC 20549 Re: Tanke Biosciences Inc.

March 14, 2024

PO Box 281077 Nashville, TN 37228 315 Deadrick Street Nashville, TN 37203 615-476-1151 Steve@SteveMillslaw.

AMENDED AND RESTATED BYLAWS Tanke Biosciences Corp.

EXHIBIT 3.1(ii) AMENDED AND RESTATED BYLAWS OF Tanke Biosciences Corp. I. SHAREHOLDER’S MEETING. .01 Annual Meetings. The annual meeting of the shareholders of this Corporation, for the purpose of election of Directors and for such other business as may come before it, shall be held at the registered office of the Corporation, or such other places, either within or without the State of Nevada, as

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Tanke Biosciences Corp. (Exact name of registrant as specified in its charter) Nevada 26-3853855 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 1333

EX-3.1(I)

EXHIBIT 3.1(i)

- FORM 1512G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-53529 Tanke Biosciences Corp. (Exact name of registrant as specified in

19 West 44th Street, 12th Floor New York, NY 10036-6101 Phone 212-381-4700 Fax 212-381-4811 Web www.uhy-us.com

Exhibit 16.1 19 West 44th Street, 12th Floor New York, NY 10036-6101 Phone 212-381-4700 Fax 212-381-4811 Web www.uhy-us.com December 26, 2013 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by Tanke Biosciences Corporation (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursua

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 26, 2013 (December 19, 2013) Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction of

Financial Statements and Exhibits, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 22, 2013 (September 30, 2013) Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction of

Tanke Biosciences Corporation Room 2801, East Tower of Hui Hao Building, No. 519 Machang Road, Pearl River New City, Guangzhou, People’s Republic of China

Exhibit 99.1 Tanke Biosciences Corporation Room 2801, East Tower of Hui Hao Building, No. 519 Machang Road, Pearl River New City, Guangzhou, People’s Republic of China To our valued Notes holders, I would like to take this opportunity to provide a quick update as to where we stand on the repayment of the outstanding balance to the holders of the 8% Senior Convertible Notes issued on February 9, 20

Quarterly Report - QUARTERLY REPORT

f10q0913tankebio.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Nu

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 30, 2013 Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction of incorporation) (Comm

Tanke Biosciences Corporation

EX-99.1 2 f8k093013ex99itankebio.htm RESIGNATION LETTER Exhibit 99.1 Tanke Biosciences Corporation September 30, 2013 Mr. Guixiong Qiu, CEO Chairman of the Board of Directors Tanke Biosciences Corporation Dear Mr. Qiu, It is with most regret that I hereby submit my resignation as Chief Financial Officer of Tanke Biosciences Corporation, effectively immediately. It was a difficult decision as I enj

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 23, 2013 Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction of incorporation) (Commiss

AMENDMENT TO PROMISSORY NOTES

EX-10.1 2 f8k082313ex10itanke.htm AMENDMENT TO PROMISSORY NOTES Exhibit 10.1 AMENDMENT TO PROMISSORY NOTES This AMENDMENT TO PROMISSORY NOTES (this “Amendment”) dated as of August 23, 2013, is entered into by Tanke Biosciences Corporation (formerly known as Greyhound Commissary, Inc.), a Nevada corporation (the “Company”), and Euro Pacific Capital, Inc., as Investor Representative (the “Investor R

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2013 o TRANSITION REPORT PU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-53529 TANKE BIOS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2013 o TRANSITION REPORT P

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2013 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-53529 TANKE BIO

- NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response………………2.50 SEC FILE NUMBER 000-53529 CUSIP NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K ý Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: March 31, 2013 o T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53465 TANKE BIOSCIEN

- ANNUAL REPORT EXTENSION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: June 30, 2012 Estimated average burden hours per response………………………... 2.50 SEC FILE NUMBER 000-53529 CUSIP NUMBER (Check one): ý Form 10-K o Form 20-F o Form 11-K ¨ Form 10-Qo Form 10-D o Form N-SAR o Form N-CSR For Period Ended: December 31, 2

To our valued convertible note holders,

EX-99.1 2 f8k020913ex99itanke.htm LETTER, DATED FEBRUARY 13, 2013, TO INVESTORS THAT INVESTED IN THE COMPANY?S FEBRUARY 9, 2011 FINANCING Exhibit 99.1 To our valued convertible note holders, I would like to take this opportunity to thank you for your support over the past 2 years as Tanke has worked hard to grow the business. As a result of your investment, we have succeeded in increasing our reve

Financial Statements and Exhibits, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

8-K 1 f8k020913tanke.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2013 Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or oth

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2012 Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction of incorporation) (Comm

December 24, 2012

EX-16.1 2 f8k122012ex16itanke.htm LETTER FROM EFP ROTENBERG LLP, DATED DECEMBER 24, 2012 Exhibit 16.1 December 24, 2012 Office of the Chief Accountant Securities and Exchange Commission 460 Fifth Street N. W. Washington, DC 20549 Dear Sirs: We have received a copy of, and are in agreement with, the statements being made by Tanke Biosciences Corporation (the “Registrant”) in Item 4.01 of its Form 8

-

Tanke Biosciences Corporation c/o Guangzhou Tanke Industry Co., Ltd. Room 2801, East Tower of Hui Hao Building No. 519 Machang Road Pearl River New City, Guangzhou People’s Republic of China 510627 December 7, 2012 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Re: Tanke Biosciences Corporation Registration Statement

Martin Hu Senior Partner [email protected] +86 21 5010-1666 *988

Exhibit 5.3 Martin Hu Senior Partner [email protected] +86 21 5010-1666 *988 4 January 2011 Euro Pacific Capital, Inc. 88 Post Road West 3rd Floor Westport, CT 06880 Tel: 203 662 9700 Fax: 203 662 9771 Re: CORPORATE STRUCTURES AND RELATED ISSUES OF GUANGZHOU TANKE INDUSTRY CO., LTD., ITS SUBSIDIARIES AND BRANCH Dear Sir/Madam: We are a firm of lawyers qualified to practice and practicing in

- AMENDED REGISTRATION STATEMENT

As filed with the Securities and Exchange Commission on November 21, 2012 Registration No.

-

Tanke Biosciences Corporation c/o Guangzhou Tanke Industry Co., Ltd. Room 2801, East Tower of Hui Hao Building No. 519 Machang Road Pearl River New City, Guangzhou People’s Republic of China 510627 November 21, 2012 VIA EDGAR Mr. H. Roger Schwall, Assistant Director Division of Corporation Finance Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: Tanke Biosciences Cor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2012 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-53529 TANKE

Initial: 13

Exhibit 5.3 Martin Hu Senior Partner [email protected] +86 21 5010-1666 *988 4 January 2011 Euro Pacific Capital, Inc. 88 Post Road West 3rd Floor Westport, CT 06880 Tel: 203 662 9700 Fax: 203 662 9771 Re: CORPORATE STRUCTURES AND RELATED ISSUES OF GUANGZHOU TANKE INDUSTRY CO., LTD., ITS SUBSIDIARIES AND BRANCH Dear Sir/Madam: We are a firm of lawyers qualified to practice and practicing in

- AMENDED REGISTRATION STATEMENT

As filed with the Securities and Exchange Commission on September 28, 2012 Registration No.

-

Tanke Biosciences Corporation c/o Guangzhou Tanke Industry Co., Ltd. Room 2801, East Tower of Hui Hao Building No. 519 Machang Road Pearl River New City, Guangzhou People’s Republic of China 510627 September 28, 2012 VIA EDGAR Mr. H. Roger Schwall, Assistant Director Division of Corporation Finance Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: Tanke Biosciences Co

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2012 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-53529 TANKE BI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2012 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-53529 TANKE BIOS

-

As filed with the Securities and Exchange Commission on August 9 , 2012 Registration No.

-

Tanke Biosciences Corporation c/o Guangzhou Tanke Industry Co., Ltd. Room 2801, East Tower of Hui Hao Building, No. 519 Machang Road Pearl River New City, Guangzhou, People’s Republic of China 510627 August 9, 2012 VIA EDGAR Mr. H. Roger Schwall, Assistant Director Division of Corporation Finance Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: Tanke Biosciences Corp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2012 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-53529 TANKE BIOSCIENCES CO

-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: June 30, 2012 Estimated average burden hours per response 2.50 SEC FILE NUMBER 000-53529 CUSIP NUMBER (Check one): ¨ Form 10-K o Form 20-F o Form 11-K ý Form 10-Qo Form 10-D o Form N-SAR o Form N-CSR For Period Ended: March 31, 2012 o Transitio

-

Tanke Biosciences Corporation c/o Guangzhou Tanke Industry Co., Ltd. Room 2801, East Tower of Hui Hao Building, No. 519 Machang Road Pearl River New City, Guangzhou, People’s Republic of China 510627 April 27, 2012 VIA EDGAR Mr. H. Roger Schwall, Assistant Director Division of Corporation Finance Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: Tanke Biosciences Corp

-

As filed with the Securities and Exchange Commission on April 27 , 2012 Registration No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-53465 TANKE BIOSCIEN

-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: June 30, 2012 Estimated average burden hours per response . . . . . 2.50 SEC FILE NUMBER 000-53529 CUSIP NUMBER (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: December 31, 20

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 2) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 20, 2012 Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction of in

-

Tanke Biosciences Corporation c/o Guangzhou Tanke Industry Co., Ltd. Room 2801, East Tower of Hui Hao Building, No. 519 Machang Road Pearl River New City, Guangzhou, People’s Republic of China 510627 March 15, 2012 VIA EDGAR Mr. Ethan Horowitz, Accounting Branch Chief Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: Tanke Biosciences Corporation Form 8-K filed Januar

EX-16.1

-

As filed with the Securities and Exchange Commission on February 10, 2012 Registration No.

LOAN AGREEMENT

Unofficial English Translation Contract No.: KAI GONG LIU 2009021 LOAN AGREEMENT Borrower (Party A): Guangzhou Tanke Bio-tech Co., Ltd. Add.: Zip Code: Legal representative (Person in charge): Gao Bi Fax: Phone: Lender (Party B): China Construction Bank, Guangzhou Economic and Technical Development Zone Branch Add.: Zip Code: Legal representative (Person in charge): Li Qili Fax: Phone: According t

-

Tanke Biosciences Corporation c/o Guangzhou Tanke Industry Co., Ltd. Room 2801, East Tower of Hui Hao Building, No. 519 Machang Road Pearl River New City, Guangzhou, People’s Republic of China 510627 February 10, 2012 VIA EDGAR Mr. H. Roger Schwall, Assistant Director Division of Corporation Finance Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: Tanke Biosciences C

SECURITIES PURCHASE AGREEMENT

EX-10.1 2 e609281ex10-1.htm Execution Copy SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated February 9, 2011, is between Greyhound Commissary, Inc. (the “Company”), a Nevada corporation, and each purchaser identified on Schedule A hereto (each, including their respective successors and assigns, an “Investor” and collectively, the “Investors”) and, with res

Form of Employment Agreement

[Unofficial English Translation] Form of Employment Agreement Party A: Guangzhou Tanke Industry Co.

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant, Other Events -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 20, 2012 Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction of incorporation) (Comm

January 31, 2012

January 31, 2012 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Tanke Biosciences Corporation Dear Sirs/Madams: We have read Item 4.01 of the current report on Form 8-K dated January 20, 2012 of Tanke Biosciences Corporation (the “Registrant”) and we agree with such statements concerning our firm except for the following. At the time our engagement ended, we had n

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant, Other Events

8-K 1 e6092468k-tanke.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 20, 2012 Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction

Tanke BioSciences Corporation Appoints EFP Rotenberg, LLP as Independent Registered Public Accounting Firm

EX-99.1 2 e609246ex99-1.htm PRESS RELEASE FOR IMMEDIATE RELEASE Tanke BioSciences Corporation Appoints EFP Rotenberg, LLP as Independent Registered Public Accounting Firm New York, NY and Guangzhou, China, January 26, 2012 – Tanke BioSciences Corporation (OTCBB: TNBI), a China-based integrated biotech company that develops, manufactures, and markets animal feed additives and livestock nutritional

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q R QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2011 Or £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-53529 TANKE BIOSCIENCE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2012 Estimated average burden hours per response . . . . . 2.50 SEC FILE NUMBER 333-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2012 Estimated average burden hours per response . . . . . 2.50 SEC FILE NUMBER 333-152535 CUSIP NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: September 30,

As filed with the Securities and Exchange Commission on November 4, 2011

As filed with the Securities and Exchange Commission on November 4, 2011 Registration No.

LOAN AGREEMENT

Unofficial English Translation Contract No.: KAI GONG LIU 2009021 LOAN AGREEMENT Borrower(Party A):Guangzhou Tanke Bio-tech Co., Ltd. Add.: Zip Code: Legal representative(Person in charge): Gao Bi Fax: Phone: Lender(Party B): China Construction Bank, Guangzhou Economic and Technical Development Zone Branch Add.: Zip Code: Legal representative(Person in charge): Li Qili Fax: Phone: According to the

-

575 Madison Avenue New York, NY 10022-2585 212.940.8800 tel 212.940.8776 fax Evan L. Greebel [email protected] 212.940.6383 direct 212.894.5883 fax November 7, 2011 Via EDGAR and Federal Express H. Roger Schwall Assistant Director Securities and Exchange Commission 100 F Street N.E. Washington D.C. 20549 Re: Tanke Biosciences Corporationg Amendment No. 2 to Registration Statement on Form

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Amendment No. 2)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Amendment No. 2) R QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2011 Or £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-53529 T

December 31,

GUANGZHOU TANKE INDUSTRY CO., LTD. CONSOLIDATED FINANCIAL STATEMENTS AS OF AND FOR THE YEAR ENDED DECEMBER 31, 2010 and 2009 GUANGZHOU TANKE INDUSTRY CO., LTD. INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 2 CONSOLIDATED BALANCE SHEETS 3 CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME 4 CONSOLIDATED STATEMENTS OF SHAREHOLDERS? EQ

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Amendment No. 1) R QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2011 Or £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-53529 T

Effect of

Pro Forma Financial Information Background Information Regarding Pro Forma Financial Statements On January 3, 2011 China Flying Development Limited, a Hong Kong incorporated company (“China Flying”), and Golden Genesis Limited, a British Virgin Islands company (“Golden Genesis”), the sole stockholder of China Flying, entered into a Share Exchange Agreement (the “Share Exchange”) with Greyhound Commissary, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Amendment No. 2) R QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2011 Or £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-53529

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 9, 2011 Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction of incorporation) (Comm

By: /s/ Guixiong Qiu Name: Guixiong Qiu Title: Chairman of the Board, Chief Executive Officer and President

October 20, 2011 Via EDGAR and Federal Express Ethan Horowitz Branch Chief Securities and Exchange Commission 100 F Street N.

LOS ANGELES

575 Madison Avenue New York, NY 10022-2585 212.940.8800 tel 212.940.8776 fax Evan L. Greebel [email protected] 212.940.6383 direct 212.894.5883 fax October 20, 2011 Via EDGAR and Federal Express Ethan Horowitz Branch Chief Division of Corporate Finance Securities and Exchange Commission 100 F Street N.E. Washington D.C. 20549 Re: Tanke Biosciences Corporation Item 4.02 of Current Report o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 13, 2011 Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction of incorporation) (Commis

LOS ANGELES

575 Madison Avenue New York, NY 10022-2585 212.940.8800 tel 212.940.8776 fax Evan L. Greebel [email protected] 212.940.6383 direct 212.894.5883 fax August 29, 2011 Via EDGAR and Federal Express Ethan Horowitz Branch Chief Securities and Exchange Commission 100 F Street N.E. Washington D.C. 20549 Re: Tanke Biosciences Corporation Item 4.02 Form 8-K Filed August 8, 2011 File No. 000-53529 D

-

CORRESP 1 filename1.htm 575 Madison Avenue New York, NY 10022-2585 212.940.8800 tel 212.940.8776 fax.. Evan L. Greebel [email protected] 212.940.6383 direct 212.894.5883 fax August 24, 2011 Via EDGAR and Federal Express H. Roger Schwall Assistant Director Securities and Exchange Commission 100 F Street N.E. Washington D.C. 20549 Re: Tanke Biosciences Corporation Amendment No. 1 to Registr

As filed with the Securities and Exchange Commission on August __, 2011

As filed with the Securities and Exchange Commission on August , 2011 Registration No.

Land Lease Contract

Land Lease Contract Leaser: Guangzhou Baoyuhua Industry Co., Ltd. (hereinafter referred to as party A) Lessee: Guangzhou Tanke Industry Co., Ltd. (hereinafter referred to as party B) On November 21st, 2003, party A and party B signed the Land Lease Agreement and mutually agreed that Party A shall have the right and obligations to handle transition of Land-Use Right certificate and change of land s

LOAN AGREEMENT

Unofficial English Translation Contract No.: KAI GONG LIU 2009021 LOAN AGREEMENT Borrower(Party A):Guangzhou Tanke Bio-tech Co., Ltd. Add.: Zip Code: Legal representative(Person in charge): Gao Bi Fax: Phone: Lender(Party B): China Construction Bank, Guangzhou Economic and Technical Development Zone Branch Add.: Zip Code: Legal representative(Person in charge): Li Qili Fax: Phone: According to the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q R QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2011 Or £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-53529 TANKE BIOSCIENCES COR

LOS ANGELES

575 Madison Avenue New York, NY 10022-2585 212.940.8800 tel 212.940.8776 fax Evan L. Greebel [email protected] 212.940.6383 direct 212.894.5883 fax August 19, 2011 Via EDGAR and Federal Express Ethan Horowitz Branch Chief Securities and Exchange Commission 100 F Street N.E. Washington D.C. 20549 Re: Tanke Biosciences Corporation Item 4.02 Form 8-K Filed August 8, 2011 File No. 000-53529 D

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A R QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2011 Or £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-53529 TANKE BIOSCIENCES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2012 Estimated average burden hours per response . . . . . 2.50 SEC FILE NUMBER 333-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2012 Estimated average burden hours per response . . . . . 2.50 SEC FILE NUMBER 333-152535 CUSIP NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: June 30, 2011

December 31,

CHINA FLYING DEVELOPMENT LTD. FINANCIAL STATEMENTS AS OF AND FOR THE YEAR ENDED DECEMBER 31, 2010 and 2009 CHINA FLYING DEVELOPMENT LTD. INDEX TO FINANCIAL STATEMENTS Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 3 CONSOLIDATED BALANCE SHEETS 4 CONSOLIDATED STATEMENTS OF INCOME 5 CONSOLIDATED STATEMENTS OF SHAREHOLDER’S EQUITY 6 CONSOLIDATED STATEMENTS OF CASH FLOWS 7 NOTES TO THE C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 9, 2011 Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction of incorporation) (Comm

PRO FORMA FINANCIAL INFORMATION

PRO FORMA FINANCIAL INFORMATION Background Information Regarding Pro Forma Financial Statements On January 3, 2011, Guangzhou Kanghui Agricultural Technology Co.

December 31,

GUANGZHOU TANKE INDUSTRY CO., LTD. CONSOLIDATED FINANCIAL STATEMENTS AS OF AND FOR THE YEAR ENDED DECEMBER 31, 2010 and 2009 GUANGZHOU TANKE INDUSTRY CO., LTD. INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 2 CONSOLIDATED BALANCE SHEETS 3 CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME 4 CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQ

LOS ANGELES

575 Madison Avenue New York, NY 10022-2585 212.940.8800 tel 212.940.8776 fax.. Evan L. Greebel [email protected] 212.940.6383 direct 212.894.5883 fax August 12, 2011 Via EDGAR and Federal Express Ethan Horowitz Branch Chief Securities and Exchange Commission 100 F Street N.E. Washington D.C. 20549 Re: Tanke Biosciences Corporation Item 4.02 Form 8-K Filed August 8, 2011 File No. 000-53529

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 5, 2011 Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction of incorporation) (Commissi

EMPLOYMENT AGREEMENT

Exhibit 10.1 EMPLOYMENT AGREEMENT THIS AGREEMENT is effective as of August 1, 2011, by and between Tanke Biosciences Corporation, a Nevada corporation (the ?Company?), and Gilbert Lee (the ?Executive?). In consideration of the mutual covenants herein contained and of the mutual benefits herein provided, the Company and the Executive agree as follows: 1. Representations and Warranties. The Executiv

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 26, 2011 Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction of incorporation) (Commissio

LOS ANGELES

575 Madison Avenue New York, NY 10022-2585 212.940.8800 tel 212.940.8776 fax.. Evan L. Greebel [email protected] 212.940.6383 direct 212.894.5883 fax July 4, 2011 Via EDGAR and Federal Express H. Roger Schwall Assistant Director Securities and Exchange Commission 100 F Street N.E. Washington D.C. 20549 Re: Tanke Biosciences Corporation Current Report on Form 8-K/A Filed June 20, 2011 File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 2) CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 2) CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 17, 2011 Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction

Sadler, Gibb & Associates 291 South 200 West Farmington, UT 84025 Phone: (206) 407-5738 Fax: (801) 660-2230

Exhibit 16.1 Sadler, Gibb & Associates 291 South 200 West Farmington, UT 84025 Phone: (206) 407-5738 Fax: (801) 660-2230 [email protected] June 30, 2011 Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Dear Ladies and Gentlemen: I am the former independent registered public accounting firm for Tanke Biosciences Corporation (the “Company”). I have read the Company’s discl

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 17, 2011 Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 17, 2011 Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction of incorporation) (Commissio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q R QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2011 Or £ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-53529 TANKE BIOSCIENCES CO

SADLER, GIBB & ASSOCIATES, L.L.C. CERTIFIED PUBLIC ACCOUNTANTS Registered with the Public Company Accounting Oversight Board

SADLER, GIBB & ASSOCIATES, L.L.C. CERTIFIED PUBLIC ACCOUNTANTS Registered with the Public Company Accounting Oversight Board May 19, 2011 Securities and Exchange Commission 450 Fifth Street N.W. Washington, D.C. 20549 Ladies and Gentlemen: We have read the statements of Tanke Biosciences Corp. (f/k/a Greyhound Commissary, Inc.) pertaining to our firm included under Item 4.01 of Form 8-K dated May

Unofficial English Translation PROMISSORY NOTE

Exhibit 99.3 Unofficial English Translation Of PROMISSORY NOTE RMB 21,882,834.60 New York, New York December 24, 2010 FOR VALUE RECEIVED, each of Mr.Guixiong Qiu, residing at Room 401, 5 building cha shan qui South China Agricultural University dayuan No 483 tianhe qui wu shan road Guangzhou city Guangdong P.R.China, Mr. Bi Gao residing at Room 704 , No 10 tianhe guanghe road Guangzhou city Guangd

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2012 Estimated average burden hours per response . . . . . 2.50 SEC FILE NUMBER 333-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2012 Estimated average burden hours per response . . . . . 2.50 SEC FILE NUMBER 333-152535 CUSIP NUMBER (Check one): oForm 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: March 31, 2011

As filed with the Securities and Exchange Commission on May 13, 2011

As filed with the Securities and Exchange Commission on May 13, 2011 Registration No.

SECURITIES PURCHASE AGREEMENT

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated February 9, 2011, is between Greyhound Commissary, Inc. (the “Company”), a Nevada corporation, and each purchaser identified on Schedule A hereto (each, including their respective successors and assigns, an “Investor” and collectively, the “Investors”) and, with respect to certain sections hereo

-

(end)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 9, 2011 Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction of incorporation) (Commis

December 31,

Exhibit 99.1 GUANGZHOU TANKE INDUSTRY CO., LTD. CONSOLIDATED FINANCIAL STATEMENTS AS OF AND FOR THE YEAR ENDED DECEMBER 31, 2010 and 2009 GUANGZHOU TANKE INDUSTRY CO., LTD. INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 2 CONSOLIDATED BALANCE SHEETS 3 CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME 4 CONSOLIDATED STATEMENTS OF SHA

Pro Forma Adjustments

Exhibit 99.2 Pro Forma Financial Information Background Information Regarding Pro Forma Financial Statements On January 3, 2011 China Flying Development Limited, a Hong Kong incorporated company (“China Flying”), and Golden Genesis Limited, a British Virgin Islands company (“Golden Genesis”), the sole stockholder of China Flying, entered into a Share Exchange Agreement (the “Share Exchange”) with

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 333-152535 TANKE BIOSCIENCES CORPORATION (Exact Name of Registrant as

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Tanke Biosciences Corporation (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 87583Y 107 (CUSIP Number) Guixiong Qiu Chief Executive Officer Room 2801, East Tower of Hui Hao Building, No. 519 Machang Road Pearl River New City, Guangzhou, Peop

As filed with the Securities and Exchange Commission on February 14, 2011

As filed with the Securities and Exchange Commission on February 14, 2011 Registration No.

Tanke Biosciences Corporation List of Subsidiaries

Tanke Biosciences Corporation List of Subsidiaries Subsidiary Jurisdiction of Incorporation or Organization 1.

Call Option Agreement

EXECUTION VERSION Call Option Agreement This Call Option Agreement (this ?Agreement?) is entered into as of January 3rd, 2011 by and among: (i) Golden Genesis Limited (the ?Golden Genesis? or ?Grantor?), a British Virgin Islands company; (ii) Qiu Guixiong, Gao Bi, Liang Xiuzhen and Teng Bing, all Chinese nationals (collectively the ?Grantees? or separately a ?Grantee?); and (iii) Wong Kwai Ho (?Ms.

September 30,

GUANGZHOU TANKE INDUSTRY CO., LTD. CONSOLIDATED FINANCIAL STATEMENTS AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2009 and 2008, AND AS OF SEPTEMBER 30, 2010 (UNAUDITED) AND FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2010 AND 2009 (UNAUDITED) GUANGZHOU TANKE INDUSTRY CO., LTD. INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 2 CONSOLIDATED BALANCE

Option Agreement

EXECUTION VERSION Option Agreement This Option Agreement (this ?Agreement?) is entered into by and among Guangzhou Kanghui Agricultural Technology Co.

Voting Rights Proxy Agreement

EXECUTION VERSION Voting Rights Proxy Agreement This Voting Rights Proxy Agreement (this ?Agreement?) is entered into by and among Guangzhou Kanghui Agricultural Technology Co.

Pro Forma Adjustments

Pro Forma Financial Information Background Information Regarding Pro Forma Financial Statements On January 3, 2011 China Flying Development Limited, a Hong Kong incorporated company (?China Flying?), and Golden Genesis Limited, a British Virgin Islands company (?Golden Genesis?), the sole stockholder of China Flying, entered into a Share Exchange Agreement (the ?Share Exchange?) with Greyhound Commissary, Inc.

GREYHOUND COMMISSARY, INC. COMMON STOCK PURCHASE WARRANT

NEITHER THIS WARRANT NOR THE SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

EX-3.2

REGISTRATION RIGHTS AGREEMENT

REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated February 9, 2011, is between Greyhound Commissary, Inc.

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Change in Shell Company Status, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 9, 2011 Tanke Biosciences Corporation (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction of incorporation) (Commis

Operating Agreement

Operating Agreement EXECUTION VERSION Operating Agreement This Operating Agreement (this “Agreement”) is entered into by and among Guangzhou Kanghui Agricultural Technology Co.

GREYHOUND COMMISSARY, INC. PLACEMENT AGENT WARRANT Initial Holder: [____________] Original Issue Date: February 9, 2011 No. of Shares Subject to Warrant: [___] Exercise Price Per Share: $1.15 Expiration Time: 5:00 p.m., New York time, on February 9,

NEITHER THIS WARRANT NOR THE SECURITIES INTO WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

EX-3.3

Equity Pledge Agreement

Equity Pledge Agreement EXECUTION VERSION Equity Pledge Agreement This Equity Pledge Agreement (this ?Agreement?) is entered into by and among Guangzhou Kanghui Agricultural Technology Co.

Greyhound Commissary Completes Share Exchange and $7.67 Million Financing Company Acquires Guangzhou Tanke Industry Co., Ltd., a Leading and Innovative Manufacturer of Environmentally Friendly Feed Additives in China

Greyhound Commissary Completes Share Exchange and $7.67 Million Financing Company Acquires Guangzhou Tanke Industry Co., Ltd., a Leading and Innovative Manufacturer of Environmentally Friendly Feed Additives in China SALT LAKE CITY, Utah & GUANGZHOU, China - Greyhound Commissary, Inc. (OTCBB:GHND) has consummated a share exchange transaction and concurrent US $7.67 million private placement pursua

GREYHOUND COMMISSARY, INC. 8% SENIOR CONVERTIBLE NOTE

THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.

Consulting Services Agreement

Consulting Service Agreement EXECUTION VERSION Consulting Services Agreement This Consulting Services Agreement (this ?Agreement?) is entered into by and between Guangzhou Kanghui Agricultural Technology Co.

SECURITIES ESCROW AGREEMENT

Execution Copy SECURITIES ESCROW AGREEMENT This Securities Escrow Agreement (the ?Agreement?), dated as of February 9, 2011, is entered into by and among Greyhound Commissary, Inc.

SECURITIES PURCHASE AGREEMENT

Execution Copy SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated February 9, 2011, is between Greyhound Commissary, Inc.

ESCROW AGREEMENT

ESCROW AGREEMENT This ESCROW AGREEMENT, dated as of February 9, 2011 (this ?Agreement?), is entered into by and among Greyhound Commissary, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14F-1 INFORMATION STATEMENT PURSUANT TO SECTION 14(f) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 14F-1 THEREUNDER GREYHOUND COMMISSARY, INC. (Exact Name of Registra

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14F-1 INFORMATION STATEMENT PURSUANT TO SECTION 14(f) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 14F-1 THEREUNDER GREYHOUND COMMISSARY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada (State or other jurisdiction of incorporation or organization) 000-53529 Commission File Number 26-3853855 (I.R

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

Commission File No. 000-53529 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [X] Definitive Information Statement GREYHOUND COMM

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) x Annual Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2009 o Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For the transition period from to Commission File Number: 000-535

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

Commission File No. 000-53529 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement GREYHOUND COMM

Leonard E. Neilson A PROFESSIONAL CORPORATION LEONARD E. NEILSON 8160 SOUTH HIGHLAND DRIVE, SUITE 104 ATTORNEY AT LAW SANDY, UTAH 84093 TELEPHONE: (801) 733-0800 FAX: (801) 733-0808 E-MAIL: [email protected] January 12, 2011

Leonard E. Neilson A PROFESSIONAL CORPORATION LEONARD E. NEILSON 8160 SOUTH HIGHLAND DRIVE, SUITE 104 ATTORNEY AT LAW SANDY, UTAH 84093 TELEPHONE: (801) 733-0800 FAX: (801) 733-0808 E-MAIL: [email protected] January 12, 2011 Securities and Exchange Commission Attn: Maryse Mills-Apenteng, Special Counsel Division of Corporation Finance 100 F Street NE Washington, D.C. 20549 Via Edgar Re: Greyhoun

SHARE EXCHANGE AGREEMENT

Execution Version SHARE EXCHANGE AGREEMENT This SHARE EXCHANGE AGREEMENT (this “Agreement”) is entered into as of this January, 3, 2011, by and between Greyhound Commissary, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 3, 2011 Greyhound Commiss

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 3, 2011 Greyhound Commissary, Inc. (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction (Commission (IRS Employer of

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934

Commission File No. 000-53529 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement GREYHOUND COMM

Leonard E. Neilson A PROFESSIONAL CORPORATION LEONARD E. NEILSON 8160 South Highland Drive, Suite 104 Attorney at Law Sandy, Utah 84093 Telephone: (801) 733-0800 Fax: (801) 733-0808 E-mail: [email protected] January 5, 2011

Leonard E. Neilson A PROFESSIONAL CORPORATION LEONARD E. NEILSON 8160 South Highland Drive, Suite 104 Attorney at Law Sandy, Utah 84093 Telephone: (801) 733-0800 Fax: (801) 733-0808 E-mail: [email protected] January 5, 2011 Securities and Exchange Commission Office of Document Control 100 F Street NE Washington, D.C. 20549 Via Edgar Re: Greyhound Commissary, Inc. File No. 000-53529 Schedule 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended September 30, 2010 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-53529 GREYHOUND COMM

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended June 30, 2010 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-53529 GREYHOUND COMMISSAR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended March 31, 2010 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-53529 GREYHOUND COMMISSARY

April 30, 2010

April 30, 2010 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read the statements of Greyhound Commissary, Inc.. (the ?Company?) pertaining to our firm included under Item 4.01 of Form 8-K, to be filed on or about April 30, 2010 and agree with such statements as they pertain to our firm. We have no basis to agree or disagree with other stat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 22, 2010 GREYHOUND COMMISSARY, INC. (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction (Commission (IRS Employer of

Leonard E. Neilson Attorney at Law 8160 South Highland Drive Suite 104 Sandy, Utah 84093

Cover Letter Leonard E. Neilson Attorney at Law 8160 South Highland Drive Suite 104 Sandy, Utah 84093 Phone: (801) 733-0800 Fax: (801) 733-0808 April 27, 2010 Securities and Exchange Commission Office of Document Control 450 Fifth Street N.W. Washington, D.C. 20549 VIA: EDGARLink Re: Greyhound Commissary, Inc. File No. 000-53529 Form 10-K (for the period ended December 31, 2009) To Whom It May Con

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x Annual Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2009 o Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For the transition period from to Commission File Number: 000-53529 GREYHOUND COMMISS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File No. 000-53529 CUSIP Number 398006 106 (Check One): x Form 10-K oForm 20-F oForm 11-K oForm 10-Q oForm 10-D oForm N-SAR oForm N-CSR For Period Ended: December 31, 2009 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended September 30, 2009 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-53529 GREYHOUND COMMISSA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File No. 000-53529 (Check One): CUSIP Number 398006 106 Form 10-K Form 20-F Form 11-K X Form 10-Q Form 10-D Form N-SAR Form N-CSR For Period Ended: September 30, 2009 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on For

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 14, 2009 GREYHOUND COMMISSARY, INC. (Exact name of registrant as specified in its charter) Nevada 000-53529 26-3853855 (State or other jurisdiction (Commission (IRS Employer o

Seale and Beers, CPAs PCAOB & CPAB Registered Auditors 50 S. Jones Blvd, Ste 202, Las Vegas, NV 89107 (888)727-8251 Fax: (888)782-2351

SEALE and BEERS, CPAs PCAOB & CPAB REGISTERED AUDITORS www.sealebeers.com November 10, 2009 Office Of the Chief Accountant Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Dear Sir/Madam: We have read the statements included under Item 4.01 in the Form 8-K dated October 14, 2009 of Greyhound Commissary, Inc. (the "Company") to be filed with the Securities and Exchange Com

-

CORRESP 1 filename1.htm Greyhound Commissary, Inc. 19 East 200 South Suite 1080 Salt Lake City, Utah 84111 September 11, 2009 Securities and Exchange Commission 100 F Street NE Washington, D.C. 20549 Via: EDGAR Re: Greyhound Commissary, Inc. SEC File No. 000–53529 Response to September 1, 2009 Letter To whom it may concern: This letter is in response to the SEC letter dated September 1, 2009 regar

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 AMENDMENT NO. 1 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) August 7, 2009 GREYH

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 AMENDMENT NO.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended June 30, 2009 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-53529 GREYHOUND COMMISSARY,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended March 31, 2009 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-53529 GREYHOUND COMMISSARY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [ X ] Annual Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2008 [ ] Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For the transition period from to Commission File Number: 000-53529 GREYHOUND C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10 GENERAL FORM FOR REGISTRANTS OF SECURITIES Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934 GREYHOUND COMMISSARY, INC. (Exact name of registrant as

As filed with the Securities and Exchange Commission on December 16, 2008 Registration No.

BY?LAWS GREYHOUND COMMISSARY, INC.

BY–LAWS OF GREYHOUND COMMISSARY, INC. Article I – OFFICES Article II – MEETINGS OF SHAREHOLDERS Article III – DIRECTORS Article IV – OFFICERS Article V – EXECUTION OF INSTRUMENTS, BORROWING OF MONEY AND DEPOSIT OF CORPORATE FUNDS Article VI – CAPITAL SHARES Article VII – EXECUTIVE COMMITTEE AND OTHER COMMITTEES Article VIII – INDEMNIFICATION, INSURANCE, AND OFFICER AND DIRECTOR CONTRACTS Article I

AGREEMENT AND PLAN OF MERGER

AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER is entered into this 1st day of November 2007 by and between Greyhound Commissary, Inc.

Articles of Incorporation (Pursuant to NRS 78)

DEAN HELLER Secretary of State 206 North Carson Street Carson City, NV 89701-4299 Document Number 20070770594-41 (775) 684 5708 File Date and Time 11/01/2007 10:28 AM Website: secretaryofstate.